Form 4 for CRMD CorMedix Inc.
Accepted 2026-01-20 00:00:00 ET · period of report 2026-01-12 · accession 0001213900-26-005425 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-20 | 2026-01-12+ | CRMD | Todisco Joseph | CEO, Dir | F - Tax | $6.94 | -40.1K | 499.0K | -7% | -$278.2K |
| D | 2026-01-20 | 2026-01-16 | CRMD | Todisco Joseph | CEO, Dir | M - OptEx | $3.38 | +29.6K | 521.7K | +6% | +$100.0K |
| D | 2026-01-20 | 2026-01-16 | CRMD | Todisco Joseph | CEO, Dir | M - OptEx | $0.00 | -29.6K | 411.2K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-12 | F | D | 17,417 | $7.15 | 492,079 | D | — | — | (F1) This transaction is being reported late due to an inadvertent administrative error. |
| 2 | Common | Common Stock | 2026-01-17 | F | D | 22,665 | $6.78 | 498,999 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-16 | M | A | 29,585 | $3.38 | 521,664 | D | — | — | (F2) The Reporting Person acquired stock through the exercise of options granted on 5/10/2022. The Reporting Person paid the exercise price in cash. No sales of stock were made. |
| 4 | Derivative | Stock Option (Right to Buy Common Stock) | 2026-01-16 | M | D | 29,585 | $0.00 | 411,245 | D | $3.38 · — to 2032-05-09 | 29,585 Common Stock | (F3) These options were granted on 5/10/2022. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date. |